跳至主要内容
临床试验/NCT05838950
NCT05838950招募中不适用

Detraining Effect of Short-term HIIT on Cardiometabolic Risk in Young Adults With Obesity

Syracuse University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年9月29日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
2
主要终点
Height

研究概览

简要总结

The primary aim of this randomized clinical trial is to compare the effects of three different HIIT protocols and a control group on cardiometabolic health in young adults with obesity. Participants will be randomly assigned to one of the following three groups, with each having varying work-to-rest ratios: 1) HIIT-A, 2) HIIT-B, 3) HIIT-C, and 4) control group. HIIT-A, HIIT-B, and HIIT-C groups will participate in six sessions of a running based HIIT program over a 2-week training period. Pre-clinical markers of cardiovascular disease, blood lipids and fasting glucose will be measured at the following three time points: baseline, post-intervention, and 2 weeks after the training cessation (i.e., measure for detraining effect). All measurements will be performed three days before the training program and three days after the intervention to avoid the effect of the last training session. Afterwards, the detraining test will be measured 2 weeks post intervention.

详细描述

Introduction

High-intensity interval training (HIIT) compared with other traditional exercise regimens has shown to be effective in improving cardiometabolic health (as measured by lipids, blood pressure [BP], insulin sensitivity, pulse wave velocity) in overweight and obese adults. By knowing which HIIT protocol is more efficacious in improving markers of cardiometabolic disease, exercise physiologists, researchers and clinicians can properly prescribe exercise medicine to obese young adults and possibly prevent disease progression. Therefore, the primary aim of the present research is to compare the effects of 3 different HIIT protocols compared with a control group on cardiometabolic health improvement in young adults with obesity.

Participants: Participants will be randomly assigned to one of the following three groups : 1) HIIT-A (5:25 s; 1:5 ratio), 2) HIIT-B (10:50 s; 1:5 ratio), 3) HIIT-C (20:100 s; 1:5 ratio), and 4) control group. HIIT-A, HIIT-B, and HIIT-C groups will participate in six sessions of running-based HIIT programs over a 2-week training period. The variables will be measured at the following three time points: baseline, post-intervention, and 2 weeks after the TC (i.e., measure for detraining effect).

High-Intensity Interval Training (six sessions over 2 weeks): Heart rate will be recorded - while performing a sprint running based on the wood court. The HIIT intensity will be set at 90% of the fastest baseline with 40 repetitions of 5-seconds work time, 20 repetitions of 10-seconds work time, or 10 repetitions of 20-seconds work time. All participants will perform one bout of sprint running for 5-, 10-, or 20- seconds followed by 25-second, 50-second, or 100-seconds resting. The supervisor will verbally encourage the running to inspire the sprint at "all-out" intensity. Note that a total of 200-seconds workout time is required per session.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 25 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Young adults with obesity (Age 18 to 25 years old, BMI ≥ 30 kg/m2).

排除标准

  • Syndromic obesity; 1) Any clinical symptoms including cognitive delay, 2) abnormalities in body structure(s), 3) organ-specific abnormalities (kidney, liver failure, excessive eating, and/or other signs of hypothalamic dysfunction such as fatigue, weakness and/or lack of interest in activities.
  • Taking weight loss medication(s)
  • Currently enrolled (or within previous 6 months) in a weight loss program;
  • An underlying disease/medications (steroids, second generation psychotropic agents, hormonal contraception, statins, antihypertensive and antidiabetic medications) that could influence carbohydrate or lipid metabolism.
  • Presence of cardiac pacemaker.
  • Current or anticipated participation in another research that would interfere with any of the outcomes.
  • Current or anticipated pregnancy.

结局指标

主要结局

Height

时间窗: Baseline

Height (cm)

Weight

时间窗: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)

Weight (kg); Change from Baseline weight at 2 week and 4 week

Body mass index

时间窗: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)

Body mass index (kg/m2); Change from Baseline BMI at 2 week and 4 week

Percentage body fat

时间窗: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)

Percentage body fat (kg); Change from Baseline percentage body fat at 2 week and 4 week

Fat mass

时间窗: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)

Fat mass (kg); Change from Baseline fat mass at 2 week and 4 week

Systolic blood pressure

时间窗: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)

Systolic blood pressure (SBP, mmHg); Change from Baseline SBP at 2 week and 4 week

Lean mass

时间窗: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)

Lean mass (kg); Change from Baseline lean mass at 2 week and 4 week

Diastolic blood pressure

时间窗: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)

Diastolic blood pressure (DBP, mmHg); Change from Baseline DBP at 2 week and 4 week

Carotid-femoral Pulse Wave Velocity (cPWV)

时间窗: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)

cPWV (m/s); Change from Baseline cPWV at 2 week and 4 week

Mean arterial pressure

时间窗: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)

Mean blood pressure (MAP, mmHg); Change from Baseline MAP at 2 week and 4 week

LDL-C

时间窗: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)

LDL-C (mg/dl); Change from Baseline LDL-C at 2 week and 4 week

Flow-mediated dilation

时间窗: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)

Flow-mediated dilation (FMD, mm); Change from Baseline FMD at 2 week and 4 week

Total cholesterol

时间窗: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)

Total cholesterol (mg/dl); Change from Baseline TC at 2 week and 4 week

Glucose

时间窗: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)

Glucose (mg/dl); Change from Baseline glucose at 2 week and 4 week

HDL-C

时间窗: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)

HDL-C (mg/dl); Change from Baseline HDL-C at 2 week and 4 week

Triglycerides

时间窗: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)

Triglycerides (TG, mg/dl); Change from Baseline TG at 2 week and 4 week

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验